维普期刊资源整合服务平台（V6.5）

384篇 您的检索式：作者名="Rosenson"

选中清除导出查看参考文献查看引证文献引用追踪共20页首页上一页第1页下一页末页 /20 跳转

	题名	作者	年代	出处	被引量
1	Cholesterol Efflux and Atheroprotection: Advancing the Concept of Reverse Cholesterol Transport显示文摘	Robert S. Rosenson H. Bryan Brewer W. Sean Davidson Zahi A. Fayad Valentin Fuster James Goldstein Marc Hellerstein Xian-Cheng Jiang Michael C. Phillips Daniel J. Rader Alan T. Remaley George H. Rothblat Alan R. Tall Laurent Yvan-Charvet	2012	Circulation2012，，15：	4
2	ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension显示文摘	Vallerie V. McLaughlin Stephen L. Archer David B. Badesch Robyn J. Barst Harrison W. Farber Jonathan R. Lindner Michael A. Mathier Michael D. McGoon Myung H. Park Robert S. Rosenson Lewis J. Rubin Victor F. Tapson John Varga	2009	Journal of the American College of Cardiology2009，，17：	2
3	前蛋白转化酶枯草溶菌素9变异、低密度脂蛋白胆固醇与神经认知功能损害的关系显示文摘尽管之前的研究引发了对抑制前蛋白转化酶枯草溶菌素9(proprotein convertase subtilisin/kexintype9,PCSK9)造成神经认知功能损害事件的关注,但近期一个第3期随机试验并没有发现药物性PCSK9抑制与神经认知损害有关。	黄洁叶鹏 Mefford MT Rosenson RS Cushman M Farkouh ME McClure LA Wadley VG Irvin MR Bittner VA Safford MM Somaratne R Monda KL Muntner P Levitan EB	2017	中华高血压杂志2017，25，12：	2
4	Statins and sepsis: multiple modifications at multiple levels显示文摘	Marius Terblanche Yaniv Almog Robert S Rosenson Terry S Smith Daniel G Hackam	2007	The Lancet Infectious Diseases2007，，5：	1
5	Pluripotenial machanisms of cardioproteotion with HMGCOA reductase inhibitor therapy 显示文摘	Rosenson RS	2001	Am J Cardiovasc Drugs2001，1，6：	1
6	Inhibition of proinflammatory cytokine production by pravastatin显示文摘	Rosenson RS Tangney CC Casey LC	2005	Lancet2005，353，9157：	1
7	High-sensitivity C-reactive protein and cardiovascular risk in patients with cornary heart disease显示文摘	ROSENSON R S KOEING W	2002	Curropin Cardiol2002，17，4：	1
8	Shear rate specific blood vis- cosity and shear stress of carotid artery in patients with lacunar infarction显示文摘	Jeong S K Rosenson R S	2013	BMC Neurology2013，13，1：	1
9	Utility of inflammatory markers in the management of coronary artery disease显示文摘	Rosenson RS Koeing W	2003	Am J Cardiol2003，92，1：	1
10	Phospholipase a2 enzymes and the risk of atherosclerosis显示文摘	Rosenson RS Hurt-Camejo E	2012	Eur Heart J2012，33，23：	1
11	Utility of inflammatory markers in the management of coronary artery disease 显示文摘	Rosenson RS Koenig W	2003	Am J Cardiol2003，92，1：	1
12	An tiatherothrombtic propertises of statins: implications for cardiovascular event reduction显示文摘	Rosenson RS Tangney CC	1998	JAMA1998，279，：	1
13	Antiatherothrombotic effects of nicotinic acid 显示文摘	ROSENSON R S	2003	Atherosclerosis2003，171，：	1
14	Inhibition of proinflammatory cytokine production by pravastatin 显示文摘	Rosenson RS Tangney CE Casev LC	1999	Lancet1999，353，9157：	1
15	Antiatherothrombotic properties of statin;implication for cardiovascular event reduction显示文摘	Rosenson PS Tangney CC	1998	JAMA1998，279，：	1
16	Effects of varespladibmethyl on biomarkers and major caixliovascular events in acutecoronary syndrome patients显示文摘	Rosenson RS Hislop C Elliott M	2010	J Am Coll Cardiol2010，56，14：	1
17	Development of semisolid casting for AZ91 and AM50 magnesium alloys显示文摘	Z Koren H Rosenson E.M Gutman Ya.B Unigovski A Eliezer	2002	Journal of Light Metals2002，，2：	1
18	An assessment of statin safety by muscle experts显示文摘	Thompson PD Clarkson P Rosenson R	2006	Am J Cardiol2006，97，8：	1
19	Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the pravastatin limitation of atherosclerosis in the coronary arteries (PLAC-Ⅰ) trial显示文摘	Rosenson RS Otvos JD Freedman DS		0，，：	1
20	Acute pulmonary embolism 显示文摘	Rosenson J	2010	N Engl J Med2010，363，20：	1

返回顶部每页显示：

共20页首页上一页第1页下一页末页 /20 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示